Sign up to save your podcasts
Or
Share Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan
We love to hear from our listeners. Send us a message.
Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the treatment of multiple hematologic malignancies.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational high-precision allogeneic cell therapy being evaluated in clinical trials for the treatment of multiple hematologic malignancies.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
765 Listeners
Science Magazine Podcast
807 Listeners
Economist Podcasts
4,256 Listeners
Freakonomics Radio
32,030 Listeners
The Long Run with Luke Timmerman
124 Listeners
Immune
271 Listeners
The Readout Loud
318 Listeners
FT News Briefing
697 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
147 Listeners
Biotech Hangout
11 Listeners
ASGCT Podcast Network
15 Listeners
Elon, Inc.
149 Listeners
Ground Truths
48 Listeners